Well, that was fast. It took Gov. Jim Justice all of one day after winning a seat in the U.S. Senate to play an exclusive game of political nepotism, appointing ...
Heather Bresch, CEO of pharmaceutical company Mylan, appeared before the US government’s House Oversight and Government Reform Committee two weeks ago. In a hearing over the price of her company ...
Inc. ( an integrated pharmaceutical company dedicated to the worldwide development and commercialization of impactful ...
After Viatris’ CEO earlier this year promised to be “opportunistic ... Amid GLP-1 craze, Novo and Mylan ink patent settlement in Ozempic case After a long and tortuous path to approval ...
Lifecore now operates at less than 35% utilization, meaning that it can almost triple revenue with virtually no additional ...
Mylan CEO Heather Bresch said: "I couldn't be prouder of this approval for Fulphila, the first alternative option for pegfilgrastim approved in the US, as it represents an important milestone for ...
ALK will also pay up to $320m in milestone payments to ARS in the deal, which sees the latter keep rights in the US, ...
7d
A new focus on dermatology, ophthalmology, and gastroenterology will pave ways for many untapped opportunities that Viatris can utilize with its scale and manufacturing power. We believe Viatris is in ...
CEO Scott Smith's “Phase 2” strategy focuses ... inherited from Pfizer / Mylan. The company earned ~$1.3bn in Europe in Q2, ~$1bn in the US, ~$580m in emerging markets, $350m in Japan ...
DUBLIN, Nov. 12, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the third quarter of 2024 ...
In an interview with the Financial Times, Siddharth Mittal, chief executive officer, Biocon Limited ... We may not be the ...
The Nasal Drug Delivery Technology Market is driven by the rising demand for non-invasive administration methods that enhance patient compliance and bioavailability. Innovations such as advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback